<DOC>
	<DOCNO>NCT02337036</DOCNO>
	<brief_summary>Tacrolimus cornerstone immunosuppressant child liver transplantation , use complicate narrow therapeutic index variable pharmacokinetics . This study design assess posology tacrolimus post-transplantation month liver transplantation obtain therapeutic target 10-15 ng/mL impact biological genetic factor pharmacokinetic parameter paediatric liver transplant recipient .</brief_summary>
	<brief_title>Pharmacokinetic Tacrolimus Paediatric Liver Transplant Patients</brief_title>
	<detailed_description>Tacrolimus cornerstone immunosuppressant child liver transplantation , use complicate narrow therapeutic index variable pharmacokinetics . Therapeutic drug monitoring ( TDM ) tacrolimus , base whole-blood trough concentration ( C0 ) value , mandatory use twice-daily tacrolimus ( Prograf_ ) order decrease interindividual variability exposure thereby minimize risk acute rejection occurrence adverse effect ( mainly nephrotoxicity , less extent , neurotoxicity ) . Until , C0 easy mean individual dose adjustment , one blood sample required clinician easily calculate dose need reach target . Many factor impact pharmacokinetic parameter . However adaptation time achieve target stay issue . Among factor inter intra variability pharmacokinetic tacrolimus , specific pediatric liver transplantation population . Aims : To build population pharmacokinetic model describes apparent clearance tacrolimus potential demographic , clinical genetically control factor could lead inter-patient pharmacokinetic variability within child follow liver transplantation .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Age child need liver transplantation : 6 month 12 year Formulary consent sign two parent . Children need receive tacrolimus per o ( Modigraf® ) liver transplantation associate Simulect® ( basilixumab ) posttransplantation immediately main Affiliation system social protection . Children need multi organ transplantation Hypersensibility Contraindication Modigraf® others macrolides . Patients retransplanted 14 day transplantation Patients multivisceral failure Patients introduction tacrolimus 3 day transplantation Patients need complementary immunosuppressive drug corticoid except methylprednisolone use reject Patients receive Prograf® per o iv . Patients receive Cellcept® Myfortic® Opposition sign formulary consent understand note information</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Child</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>